In malignant tumors, SAR1A exhibits complex roles, such as promoting osteosarcoma metastasis through the RhoA/YAP pathway [20] and inhibiting ERK signaling, thereby suppressing the growth of hepatocellular carcinoma (HCC) cells [21]. Here, RHOA is linked to hepatocellular carcinoma.